AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
2023 | 4 | $5,000,000 | LD-2 : 01/22/24 |
2023 | 4 | $6,000,000 | LD-2 : 01/20/24 |
2023 | 4 | $5,000,000 | LD-2 : 01/19/24 |
2023 | 4 | $6,000,000 | LD-2 : 01/15/24 |
2023 | 4 | $6,000,000 | LD-2 : 01/13/24 |
Get PRO Today
With PRO you will unlock 15 more lobbying disclosures for AbbVie Inc.